Page 5 - Pathogen Research News Today

Researchers from Cleveland Clinic's Global Center for Pathogen Research & Human Health, who have developed the nanotechnology based vaccine, say it has shown strong efficacy in preclinical disease models.

The vaccine candidate developed at the Cleveland Clinic's Global Center for Pathogen Research & Human Health shows promise in preclinical studies.

A new nanoparticle-based vaccine has demonstrated success in ferret models of COVID-19, inducing strong neutralising antibodies.

Metabolon Collaborates with Cleveland Clinic to Enable Novel Discoveries Leveraging Metabolomics to Accelerate Research, Drug Development and Precision Medicine News provided by Share this article MORRISVILLE, N.C., Feb. 18, 2021 /PRNewswire/ --  Metabolon, Inc. has entered into to a multi-year collaborative agreement with Cleveland Clinic to provide Metabolons Precision Metabolomics™ services in support of drug development and related research efforts. Metabolon will leverage its propr...

New Cleveland Clinic biorepository building aims to capitalize on Ohio-funded ‘innovation district,’ developer says Eric Heisig, cleveland.com © David Petkiewicz, cleveland.com/David Petkiewicz, cleveland.com/cleveland.com/TNS Brooks Life Sciences is building a specimen repository on Carnegie and E. 100th Street, right across from the main Cleveland Clinic campus. David Petkiewicz, cleveland.com CLEVELAND, Ohio — Developers and a company behind a new building on the Cle...

Ohio Governor Mike DeWine Week in Review (For the week ending Jan. 29, 2021) Information submitted Gov. Mike DeWine OHIO – Throughout the week, Ohio Governor Mike DeWine and Lt. Governor Jon Husted provided updates on Ohios response to the COVID-19 pandemic, as well as other state initiatives On Monday, Governor DeWine issued the following statement regarding the news that United States Senator Rob Portman would not seek re-election: “Senator Portman has worked tirelessl...

Health, education institutions unite with big money, lofty goals for Cleveland Innovation District Cleveland Clinic A new Cleveland Clinic center focused on understanding and combatting emerging pathogens will serve as an anchor for an emerging innovation district on the citys East Side. Challenging a long history of rather sporadic collaboration efforts, three health systems and two universities have forged a $565 million partnership to spark innovation and economic growth. Cleveland Clinic, U...

Credit: Cleveland Clinic CLEVELAND - Cleveland Clinic researchers have described for the first time how Zika virus (ZIKV) causes one of the most common birth defects associated with prenatal infection, called brain calcification, according to new study findings published in Nature Microbiology. The findings may reveal novel strategies to prevent prenatal ZIKV brain calcification and offer important insights into how calcifications form in other congenital infections. "Brain calcification has b...

Cause Of Common Zika Virus Birth Defect Revealed by Colleen Fleiss on  January 28, 2021 at 10:32 PM A new study has identified how Zika virus (ZIKV) causes one of the most common birth defects linked to prenatal infection, called brain calcification, according to new study findings published in Nature Microbiology. "Brain calcification has been linked to several developmental defects in infants, including motor disorders, cognitive disability, eye abnormalities, hearing defi...

Cleveland Clinic Cleveland Clinic will invest $300 million in building a Global Center for Pathogen Research and Human Health at its main campus as part of the Cleveland Innovation District announced Monday. Cleveland will be the home to Ohio’s second “innovation district,” a health-care focused, $565 million job-creation partnership with the citys three major hospitals and Case Western Reserve and Cleveland State universities. Gov. Mike DeWine said the state expects the Cleveland Innov...